Literature DB >> 25220354

Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.

Guofeng Cheng1.   

Abstract

MicroRNAs (miRNAs) belong to a class of small non-coding RNAs that regulate numerous biological processes by targeting a broad set of messenger RNAs. Recently, miRNAs have been detected in remarkably stable forms in many types of body fluids. A comparison between cancer patients and healthy individuals has clearly shown that certain types of circulating miRNAs are associated with cancer initiation and progression. Research on miRNA-based biomarkers has witnessed phenomenal growth, owing to the non-invasive nature of miRNA-based screening assays and their sensitivity and specificity in detecting cancers. Consequently, a considerable effort has been devoted to identify suitable miRNAs for cancer diagnosis and also decode the information carried by circulating miRNAs. This review highlights the current studies that focus on the identification of circulating miRNA-based diagnostic and prognostic markers, for the most prevalent types of cancer. Additionally, the review also provides an insight into the putative functions of miRNAs, and attempts to delineate the mechanisms through which they are released into the bloodstream. Moreover, methodologies and strategies for identification of circulating miRNAs in cancers are summarized. Finally, potential strategies for circulating miRNA-based cancer therapies are proposed.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarkers; Cancer diagnosis; Cancer therapy; Circulating miRNAs; Prognosis

Mesh:

Substances:

Year:  2014        PMID: 25220354     DOI: 10.1016/j.addr.2014.09.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  103 in total

1.  Detection of stably expressed piRNAs in human blood.

Authors:  Xiao Yang; Yidong Cheng; Qiang Lu; Jifu Wei; Haiwei Yang; Min Gu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Functional miR143/145 Cluster Variants and Haplotypes Are Associated with Chronic Kidney Disease: a Preliminary Case-Control Study and Computational Analyses.

Authors:  Saman Sargazi; Milad Heidari Nia; Fariba Mirani Sargazi; Roghayeh Sheervalilou; Ramin Saravani; Sara Bahrami; Shekoufeh Mirinejad; Ali Alidadi
Journal:  Appl Biochem Biotechnol       Date:  2021-01-23       Impact factor: 2.926

3.  Isolation and Characterization of Extracellular Vesicles from Adult Schistosoma japonicum.

Authors:  Juntao Liu; Lihui Zhu; Lihui Wang; Yongjun Chen; Bikash Ranjan Giri; Jianjun Li; Guofeng Cheng
Journal:  J Vis Exp       Date:  2018-05-22       Impact factor: 1.355

4.  MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor.

Authors:  Yunxiang Chen; Rui Li; Minhong Pan; Zhumei Shi; Wei Yan; Ning Liu; Yongping You; Junxia Zhang; Xiefeng Wang
Journal:  J Neurooncol       Date:  2017-05-13       Impact factor: 4.130

Review 5.  Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention.

Authors:  Nina J Chu; Todd D Armstrong; Elizabeth M Jaffee
Journal:  Clin Cancer Res       Date:  2015-01-26       Impact factor: 12.531

6.  Dual approach for the colorimetric determination of unamplified microRNAs by using citrate capped gold nanoparticles.

Authors:  Ahmed Ibrahim Nossier; Hana Abdelzaher; Marwa Matboli; Sanaa Eissa
Journal:  Mikrochim Acta       Date:  2018-03-22       Impact factor: 5.833

Review 7.  Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods.

Authors:  Guy R Adami; Jessica L Tang; Michael R Markiewicz
Journal:  Oral Oncol       Date:  2017-04-17       Impact factor: 5.337

8.  Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.

Authors:  Xiongbo Wu; Min Xia; Dayang Chen; Fang Wu; Zhifa Lv; Qiang Zhan; Yang Jiao; Wenjie Wang; Guangxia Chen; Fangmei An
Journal:  Tumour Biol       Date:  2016-09-22

Review 9.  Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine.

Authors:  Ruifang Sun; L Jeffrey Medeiros; Ken H Young
Journal:  Mod Pathol       Date:  2016-08-01       Impact factor: 7.842

10.  Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma.

Authors:  Sourav Bhattacharya; Robert Steele; Shubham Shrivastava; Sounak Chakraborty; Adrian M Di Bisceglie; Ratna B Ray
Journal:  Am J Pathol       Date:  2016-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.